Incidence, timing, and management of infections in patients receiving daratumumab for the treatment of newly diagnosed transplant-ineligible multiple myeloma in the MAIA study Meeting Abstract
| Authors: | Bahlis, N. J.; Facon, T.; Usmani, S.; Moreau, P.; Raje, N.; Zweegman, S.; Chari, A.; Perrot, A.; Manier, S.; Orlowski, R.; Goldschmidt, H.; Basu, S.; Hulin, C.; Weisel, K.; Mohty, M.; Plesner, T.; Cook, G.; Leleu, X.; Quach, H.; Venner, C. P.; Ngo, M.; Bolyard, K.; Carson, R.; Borgsten, F.; Kumar, S. |
| Abstract Title: | Incidence, timing, and management of infections in patients receiving daratumumab for the treatment of newly diagnosed transplant-ineligible multiple myeloma in the MAIA study |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S221 |
| Language: | English |
| ACCESSION: | WOS:001325737900386 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)02226-2 |
| Notes: | Meeting Abstract: P-324 -- Source: Wos |
